These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32088858)

  • 1. Puzzle of highly pathogenic human coronaviruses (2019-nCoV).
    Li J; Liu W
    Protein Cell; 2020 Apr; 11(4):235-238. PubMed ID: 32088858
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on the 2019 novel coronavirus (SARS-CoV-2).
    Wang M; Zhang N
    Future Microbiol; 2020 Jul; 15():905-918. PubMed ID: 32524843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
    Li JY; You Z; Wang Q; Zhou ZJ; Qiu Y; Luo R; Ge XY
    Microbes Infect; 2020 Mar; 22(2):80-85. PubMed ID: 32087334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to Covid-19 - A Once-in-a-Century Pandemic?
    Gates B
    N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
    [No Abstract]   [Full Text] [Related]  

  • 7. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
    Bassetti M; Vena A; Giacobbe DR
    Eur J Clin Invest; 2020 Mar; 50(3):e13209. PubMed ID: 32003000
    [No Abstract]   [Full Text] [Related]  

  • 8. Curing COVID-19.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Oct; 20(10):1101. PubMed ID: 32919520
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
    Ladoux A; Azoulay S; Dani C
    Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
    [No Abstract]   [Full Text] [Related]  

  • 11. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of a novel human coronavirus threatening human health.
    Poon LLM; Peiris M
    Nat Med; 2020 Mar; 26(3):317-319. PubMed ID: 32108160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
    Stringer KA; Puskarich MA; Kenes MT; Dickson RP
    Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979
    [No Abstract]   [Full Text] [Related]  

  • 14. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

  • 15. Three months of COVID-19: A systematic review and meta-analysis.
    Rafiq D; Batool A; Bazaz MA
    Rev Med Virol; 2020 Jul; 30(4):e2113. PubMed ID: 32420674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: What do we know so far?
    Khedkar PH; Patzak A
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13470. PubMed ID: 32220035
    [No Abstract]   [Full Text] [Related]  

  • 17. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine in Covid-19: Does the end justify the means?
    Yakoub-Agha I
    Curr Res Transl Med; 2020 Aug; 68(3):81-82. PubMed ID: 32340837
    [No Abstract]   [Full Text] [Related]  

  • 19. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 20. When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.
    Kiessling L; MacLaughlin C; Sattin S
    ACS Chem Biol; 2020 Jun; 15(6):1279-1281. PubMed ID: 32383582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.